Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above
Clinical trial NCT07354659 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07354659
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-10
- Primary completion
- 2027-03-10
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.